Correction to Story on AstraZeneca First-Quarter Earnings
April 24 2015 - 4:03AM
Dow Jones News
AstraZeneca reported a first-quarter core net profit of $1.37
billion. "AstraZeneca Reports Fall in First-Quarter Profit," at
0641 GMT, misstated the core net profit figure in the second
paragraph.
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Apr 2023 to Apr 2024